Fruth Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Fruth Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$899K	Sell	15,605 -75	-0.5%	-$4.31K	0.21%	114
2026 Q1	$950K	Hold	15,680	–	–	0.24%	108
2025 Q4	$845K	Hold	15,680	–	–	0.23%	112
2025 Q3	$707K	Sell	15,680 -450	-3%	-$21K	0.19%	120
2025 Q2	$746K	Hold	16,130	–	–	0.2%	113
2025 Q1	$983K	Hold	16,130	–	–	0.27%	92
2024 Q4	$912K	Hold	16,130	–	–	0.25%	94
2024 Q3	$834K	Sell	16,130 -150	-0.9%	-$7.04K	0.22%	106
2024 Q2	$676K	Sell	16,280 -150	-0.9%	-$6.71K	0.18%	125
2024 Q1	$890K	Buy	16,430 +100	+0.6%	+$5.09K	0.23%	105
2023 Q4	$837K	Buy	16,330 +180	+1%	+$9.45K	0.23%	104
2023 Q3	$937K	Hold	16,150	–	–	0.28%	98
2023 Q2	$1.03M	Sell	16,150 -100	-0.6%	-$6.71K	0.29%	94
2023 Q1	$1.13M	Sell	16,250 -234	-1%	-$16.5K	0.33%	90
2022 Q4	$1.19M	Sell	16,484 -250	-1%	-$18.9K	0.35%	90
2022 Q3	$1.19M	Sell	16,734 -50	-0.3%	-$3.63K	0.39%	78
2022 Q2	$1.24M	Hold	16,784	–	–	0.34%	93
2022 Q1	$1.23M	Hold	16,784	–	–	0.34%	94
2021 Q4	$1.05M	Hold	16,784	–	–	0.29%	97
2021 Q3	$993K	Sell	16,784 -7	-0%	-$461	0.31%	96
2021 Q2	$1.12M	Buy	16,791 +536	+3%	+$35K	0.33%	90
2021 Q1	$1.03M	Sell	16,255 -360	-2%	-$22.4K	0.32%	91
2020 Q4	$1.03M	Sell	16,615 -450	-3%	-$27.7K	0.36%	82
2020 Q3	$1.03M	Sell	17,065 -500	-3%	-$30.1K	0.41%	74
2020 Q2	$1.03M	Sell	17,565 -200	-1%	-$12K	0.44%	70
2020 Q1	$990K	Sell	17,765 -200	-1%	-$12.2K	0.51%	62
2019 Q4	$1.15M	Buy	17,965 +332	+2%	+$19K	0.44%	76
2019 Q3	$894K	Sell	17,633 -350	-2%	-$16.4K	0.36%	90
2019 Q2	$815K	Sell	17,983 -250	-1%	-$11.6K	0.33%	95
2019 Q1	$869K	Hold	18,233	–	–	0.36%	91
2018 Q4	$947K	Sell	18,233 -400	-2%	-$21.5K	0.45%	77
2018 Q3	$1.16M	Hold	18,633	–	–	0.47%	73
2018 Q2	$1.03M	Sell	18,633 -500	-3%	-$27K	0.44%	75
2018 Q1	$1.21M	Sell	19,133 -600	-3%	-$38.6K	0.54%	65
2017 Q4	$1.21M	Hold	19,733	–	–	0.51%	67
2017 Q3	$1.26M	Sell	19,733 -100	-0.5%	-$5.84K	0.58%	61
2017 Q2	$1.1M	Hold	19,833	–	–	0.52%	64
2017 Q1	$1.08M	Sell	19,833 -884	-4%	-$48.5K	0.5%	70
2016 Q4	$1.21M	Buy	20,717 +6	+0%	+$328	0.55%	64
2016 Q3	$1.12M	Sell	20,711 -500	-2%	-$32.1K	0.55%	60
2016 Q2	$1.56M	Sell	21,211 -216	-1%	-$15.3K	0.74%	45
2016 Q1	$1.37M	Buy	21,427 +50	+0.2%	+$3.15K	0.69%	48
2015 Q4	$1.47M	Hold	21,377	–	–	0.75%	44
2015 Q3	$1.26M	Sell	21,377 -500	-2%	-$31.7K	0.66%	51
2015 Q2	$1.46M	Sell	21,877 -900	-4%	-$59.3K	0.68%	48
2015 Q1	$1.47M	Hold	22,777	–	–	0.63%	51
2014 Q4	$1.34M	Sell	22,777 -25	-0.1%	-$1.41K	0.57%	58
2014 Q3	$1.17M	Buy	22,802 +1,575	+7%	+$78.7K	0.51%	62
2014 Q2	$1.02M	Buy	21,227 +150	+0.7%	+$7.39K	0.47%	67
2014 Q1	$1.06M	Hold	21,077	–	–	0.5%	61
2013 Q4	$1.12M	Sell	21,077 -200	-0.9%	-$10.2K	0.53%	59
2013 Q3	$984K	Sell	21,277 -800	-4%	-$35.1K	0.52%	60
2013 Q2	$986K	Buy	+22,077	New	+$958K	0.56%	58

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Fruth Investment Management's BMY Position: Q2 2026 in Review

Fruth Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 0.48% in Q2 2026, selling an estimated $4.31K and leaving 15,605 shares worth $899K. The position accounts for 0.21% of the portfolio, ranked #114.

Fruth Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.56M in Q2 2016. 915 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Fruth Investment Management held 15,605 shares of Bristol-Myers Squibb worth $899K as of Q2 2026.
Fruth Investment Management sold 75 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.31K.
Bristol-Myers Squibb made up 0.21% of Fruth Investment Management's portfolio in Q2 2026, its #114 holding.
Fruth Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Fruth Investment Management's Bristol-Myers Squibb position peaked at $1.56M in Q2 2016.
915 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fruth Investment Management's 13F filing for Q2 2026, filed 10 Jul 2026.